Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

Topical DHEA safely increases skin oil production.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Sunekos® effectively improves labia majora appearance and is well-tolerated.

A rare ovarian tumor was diagnosed in a woman from North Brazil, and surgery is the preferred treatment.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

The document did not provide enough information to summarize the causes of hair loss in pre- and postmenopausal women.

Finasteride for female hair loss has low side effects, more research needed.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.